NLRP3 and pulmonary emphysema: MCC950, a potent and specific NLRP3 inhibitor, significantly reduces inflammation and emphysema progression in cigarette smoke-exposed murine models by blocking NLRP3 ATPase activity and subsequent inflammasome assembly (92).